Karyopharm Therapeutics Inc (KPTI)

Finanzdaten der Karyopharm Therapeutics Inc-Aktie (KPTI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.66%33.43	35.07	34.08	44.04	37.93
	9.49%55.96	61.83	51.92	59.26	62.32
Selling, General, and Administrative	2.88%25.92	26.68	22.77	26.61	28.48
Research and Development	14.32%28.96	33.80	27.67	30.54	32.79
Operating Income/Loss	15.82%-22.53	-26.76	-17.84	-15.22	-24.39
Nonoperating Income/Loss	1,118%-44.50	4.37	-84.42	-17.87	-12.83
Income/Loss From Continuing Operations Before Tax	199.33%-67.02	-22.39	-102.27	-33.09	-37.21
Income Tax Expense/Benefit	100.00%-	0.00	-0.07	0.03	0.04
	199.32%-67.02	-22.39	-102.20	-33.13	-37.25
Attributable To Parent	199.32%-67.02	-22.39	-102.20	-33.13	-37.25
Basic Average Shares	31.45%0.03	0.02	0.00	0.01	0.01
Diluted Average Shares	17.09%0.03	0.02	0.00	0.01	0.01
Basic Earnings Per Share	127.45%-2.32	-1.02	-7.00	-3.82	-4.32
Diluted Earnings Per Share	87.10%-2.32	-1.24	-7.00	-3.82	-4.32